References - Therapeutic Strategies in Cancer Biology and Pathology - page 244

Saito, D., Maeshimad, Y., Nasu, T., Yamasaki, H., Tanabe, K., Sugiyama, H., et al., 2011.
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative
feedback regulator of angiogenesis. Ren. Physiol. 300, F873-F886.
Salih, D.A.M., Brunet, A., 2008. FoxO transcription factors in the maintenance of cellular
homeostasis during aging. Curr. Opin. Cell Biol. 20, 126-136.
Salim, S., Asghar, M., Taneja, M., Hovatta, I., Wu, Y.L., Saha, K., et al., 2011. Novel role
of RGS2 in regulation of antioxidant homeostasis in neuronal cells. FEBS Lett. 585,
1375-1381.
Samant, R.S., Seraj, M.J., Saunders, M.M., Sakamaki, T.S., Shevde, L.A., Harms, J.F., et al.,
2000. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp.
Metastasis 18, 683-693.
Samant, R.S., Clark, D.W., Fillmore, R.A., Cicek, M., Metge, B.J., Chandramouli, K.H., et al.,
2007. Breast cancer metastasis suppressor I (BRMSI) inhibits osteopontin transcription
by abrogating NF-kappa B activation. Mol. Cancer 6, 6.
Samanta, J., Kessler, J.A., 2004. Interactions between ID and OLIG proteins mediate the inhibi-
tory effects of BMP4 on oligodendroglial differentiation. Development 131, 4131-4142.
Sanchez, A.M., Flamini, M.I., Baldacci, C., Gogliad, L., Genazzani, A.R., Simoncini, T.,
2010. Estrogen receptor alpha promotes breast cancer cell motility and invasion via focal
adhesion kinase and N-WASP. Mol. Endocrinol. 24, 2114-2125.
Sánchez-Tilló, E., Lázaro, A., Torrent, R., Cuatrecasas, M., Vaquero, E.C., Castells, A., et al.,
2010. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chro-
matin-remodeling protein BRG1. Oncogene 29, 3490-3500.
Sang, M., Li, Y., Ozaki, T., Ono, S., Ando, K., Yamamoto, H., et al., 2006. p73-dependent
induction of 14-3-3 sigma increases the chemo-sensitivity of drug-resistant human breast
cancers. Biochem. Biophys. Res. Commun. 347, 327-333.
Sankpal, U.T., Goodison, S., Abdelrahim, M., Basha, R., 2011. Targeting sp1 transcription
factors in prostate cancer therapy. Med. Chem. 7, 518-525.
Santarius, T., Bignell, G.R., Greenman, C.D., Widaa, S., Chen, L.N., Mahoney, C.L., et al., 2010.
GLO1 - a novel amplified gene in human cancer. Genes. Chrom. Cancer 49, 711-725.
Sarbassov, D.D., Guertin, D.A., Ali, S.M., Sabtini, D.M., 2005. Phosphorylation and regula-
tion of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
Sarver, A.L., Li, L., Subramanian, S., 2010. MicroRNA miR-183 functions as an oncogene by
targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res.
70, 9570-9580.
Sayed, D., He, M., Hong, C., Gao, S., Rane, S., Yang, Z., et al., 2010. MicroRNA-21 is a
downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas
ligand. J. Biol. Chem. 285, 20281-20290.
Sbai, O., Devi, T.S., Melone, M.A.B., Feron, F., Khrestchatisky, M., Singh, L.P., et al., 2010.
RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin
expression and cytokine secretion. J. Cell. Sci. 123, 4332-4339.
Schäfer, B.W., Wicki, R., Engelkamp, D., Mattei, M.G., Heizmann, C.W., 1995. Isolation of a
YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for
a new nomenclature of the S100 calcium-binding protein family. Genomics 25, 638-643.
Schilling, S.H., Hjelmeland, A.B., Radiloff, D.R., Liu, I.M., Wakeman, T.P., Fielhauer, J.R.,
et al., 2009. NDRG4 is required for cell cycle progression and survival in glioblastoma
cells. J. Biol. Chem. 284, 25160-25169.
Schlingensiepen, K.H., Jaschinski, F., Lang, S.A., Moser, C., Geissler, E.K., Schlitt, H.J.,
et al., 2011. Transforming growth factor-beta 2 gene silencing with trabedersen (AP
12009) in pancreatic cancer. Cancer Sci. 102, 1193-1200.